Preclinical comparison of four [18F, natGa]rhPSMA-7 isomers: influence of the stereoconfiguration on pharmacokinetics.

Alexander WurzerMara ParzingerMatthias KonradRoswitha BeckThomas GüntherVeronika FelberStefanie FärberDaniel Di CarloHans-Jürgen Wester

Published in: EJNMMI research (2020)

[18F, natGa]rhPSMA-7.3 has been selected as a lead compound for clinical development of a [18F]rhPSMA-based candidate. The intraindividual differential uptake and excretion analysis in vivo allowed for an accurate comparison and assessment of radiopharmaceuticals.

Keyphrases

high resolution
stem cells
clinical evaluation
mesenchymal stem cells